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Abstract 
Purpose: To design an anthropomorphic pediatric spine 
phantom for use in the evaluation of proton therapy facilities 
for clinical trial participation by the Imaging and Radiation 
Oncology Core (IROC) Houston QA Center (formerly RPC). 
 
Methods: This phantom was designed to perform an 
end-to-end audit of the proton spine treatment process, in-
cluding simulation, dose calculation by the treatment plan-
ning system (TPS), and proton treatment delivery. The de-
sign incorporated materials simulating the thoracic spinal 
column of a pediatric patient, along with two 
thermoluminescent dosimeter (TLD)-100 capsules and 
radiochromic film embedded in the phantom for dose evalu-
ation. Fourteen potential materials were tested to determine 
relative proton stopping power (RSP) and Hounsfield unit 
(HU) values. Each material was CT scanned at 120 kVp, and 
the RSP was obtained from depth ionization scans using the 
Zebra multi-layer ion chamber (MLIC) at two energies: 160 
MeV and 250 MeV. To determine tissue equivalency, the 
measured RSP for each material was compared to the RSP 
calculated by the Eclipse TPS for a given HU.  
 
Results: The materials selected as bone, tissue, and cartilage 
substitutes were Techron HPV Bearing Grade (Boedeker 
Plastics, Inc.), solid water, and blue water, respectively. The 
RSP values did not differ by more than 1.8% between the 
two energies. The measured RSP for each selected material 
agreed with the RSP calculated by the Eclipse TPS within 
1.2%. 
 
Conclusion: An anthropomorphic pediatric proton spine 
phantom was designed to evaluate proton therapy delivery. 
The inclusion of multiple tissue substitutes increases hetero-
geneity and the level of difficulty for institutions to success-
fully treat the phantom. The following attributes will be 
evaluated: absolute dose agreement, distal range, field width, 
junction match and right/left dose profile alignment. The 
phantom will be tested at several institutions using a 5% dose 
agreement criterion, and a 5%/3mm gamma analysis criteri-
on for the film planes. 
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---------------------------------------------- 
Innovation/Impact: With the number of proton 
therapy facilities increasing nationwide, it is im-
portant to establish accuracy and consistency in the 
dose delivered in patient treatments. The IROC 
Houston QA Center (formerly the RPC) uses an-
thropomorphic phantoms as a part of the mailable 
audit program to verify dose delivery for various 
treatment techniques. This new phantom is an im-
provement over the current proton spine phantom. 
The current spine phantom contains a deteriorating 
skeleton, causing air pockets that can lead to inaccu-
rate gamma analysis calculations. The design of the 
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current spine phantom also causes curvature of the 
film when positioned, causing additional difficulties 
in the analysis. The new design includes durable 
materials that can be used in radiation dosimetry as 
tissue substitutes when irradiated with protons, 
along with a simulated spine curvature that does not 
affect the film dosimeters. The inclusion of multiple 
tissue substitutes in the phantom increases hetero-
geneity and the level of difficulty for institutions to 
conduct a successful treatment.
 
TABLE 1: Data comparing relative stopping power measurements for phantom materials tested at 160 MeV and 250 MeV 
 
*This data corresponds to the bone tissue substitute selected for the phantom. 
†The largest difference between the RSP at two proton energies was calculated for this material. 
 
TABLE 2: Data comparing measured relative stopping power measurements for phantom materials tested at 160 MeV to the relative stopping 
power calculated by the Eclipse treatment planning system for a given HU. 
 
 
 
FIG.1: Relative Stopping Power (RSP) versus Hounsfield unit calibration curve comparing tested materials with  
Eclipse treatment planning system 
